CM355

BIOLOGICAL2 trials

Sponsors

Beijing InnoCare Pharma Tech Co., Ltd., Second Xiangya Hospital of Central South University

Conditions

HematomaSystemic Lupus Erythematosus

Phase 1

A Phase I/II Study of CM355 in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL)

Active, not recruitingNCT05210868

Beijing InnoCare Pharma Tech Co., Ltd.Hematoma

Start: 2021-11-16End: 2026-12-31Target: 184Updated: 2022-01-27

Unknown Phase

Study of CM355 in Patients With Systemic Lupus Erythematosus

Not yet recruitingNCT07104344

Second Xiangya Hospital of Central South UniversitySystemic Lupus Erythematosus

Start: 2025-09-25End: 2026-10-31Target: 5Updated: 2025-08-05